Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Catalyst Pharmaceuticals, Inc.

Clinical trials sponsored by Catalyst Pharmaceuticals, Inc., explained in plain language.

Catalyst Pharmaceuticals, Inc. CPRX NASDAQ

A commercial-stage biopharma focused on rare neuromuscular and neurological diseases.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 1

New study tracks long-term safety of DMD drug vamorolone in boys

Disease control Recruiting now

This study follows 250 boys (ages 2 and older) with Duchenne muscular dystrophy who are taking vamorolone (AGAMREE). Researchers will monitor side effects, growth, bone health, heart function, and quality of life over time. The goal is to better understand the long-term safety an…

Sponsor: Catalyst Pharmaceuticals, Inc. • Aim: Disease control

Last updated Jul 22, 2026 00:00 UTC